AI assistant
Sending…
STANDARD BIOTOOLS INC. — Director's Dealing 2023
Apr 7, 2023
32853_dirs_2023-04-06_fe6d5ce2-4904-48d8-80ea-09dba345c738.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STANDARD BIOTOOLS INC. (LAB)
CIK: 0001162194
Period of Report: 2023-04-04
Reporting Person: Kim Hanjoon Alex (Chief Operating Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-04-04 | Common Stock | M | 70183 | — | Acquired | 70183 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-04-04 | Restricted Stock Units | $ | M | 70183 | Disposed | Common Stock (70183.0) | Direct |
Footnotes
F1: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock.
F2: Restricted Stock Units vest in four equal annual installments beginning April 4, 2023.
More from STANDARD BIOTOOLS INC.
Proxy Solicitation & Information Statement
2026
Apr 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24
Regulatory Filings
2026
Feb 24
Regulatory Filings
2026
Feb 5
Regulatory Filings
2026
Jan 30